UnitedHealth Group Incorporated (NYSE:UNH) Q3 2023 Earnings Conference Call October 13, 2023 8:45 AM ET
Company Participants
Andrew Witty - Chief Executive Officer
Dirk McMahon - President and Chief Operating Officer
John Rex - Executive Vice President, Chief Financial Officer
Brian Thompson - Chief Executive Officer, UnitedHealthcare
Patrick Conway - Chief Executive Officer, OptumRx
Dan Kueter - Chief Executive Officer, Employer & Individual Domestic
Roger Connor - Chief Executive Officer, OptumInsight
Dan Schumacher - Chief Strategy and Growth Officer
Amar Desai - Chief Executive Officer, OptumHealth Organization
Tim Spilker - Chief Executive Officer, UnitedHealthcare Community & State
Conference Call Participants
Lisa Gill - JPMorgan
Josh Raskin - Nephron Research
Justin Lake - Wolfe Research
Stephen Baxter - Wells Fargo
Nathan Rich - Goldman Sachs
Scott Fidel - Stephens
Kevin Fischbeck - Bank of America
Sarah James - Cantor Fitzgerald
David Windley - Jefferies
Ann Hynes - Mizuho Securities
John Ransom - Raymond James
Lance Wilkes - Bernstein
Operator
Good morning and welcome to the UnitedHealth Group Third Quarter 2023 Earnings Conference Call. A question-and-answer session will follow UnitedHealth Group’s prepared remarks. As a reminder, this call is being recorded.
Here is some important introductory information. This call contains forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the cautionary statements included in our current and periodic filings.
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP amounts is available on the financial and earning reports section of the company’s Investor Relations page at www.unitedhealthgroup.com. Information presented on this call is contained in the earnings release we issued this morning and in our Form 8-K dated October 13, 2023, which may be accessed from the Investor Relations page of the company’s website.
I will now turn the conference over to the Chief Executive Officer of UnitedHealth Group, Andrew Witty.
Andrew Witty
Good morning, and thank you for joining us. The third quarter results we reported today reflect well-balanced and durable growth, supported by disciplined execution, and a steadfast commitment to ensure high quality comprehensive care is well within reach for every person we're privileged to serve.
Evolution in our marketplace, including regulatory changes, means agility and adaptability must continue to be defining characteristics of our company. The people of Optum and UnitedHealthcare continuously strive to find new ways to innovate, serve, and grow. As a direct result of their mission-driven focus, this year we'll serve even more people more comprehensively than anticipated in the outlook we offered at the end of 2022. By the close of this year, we will serve nearly 900,000 additional patients under value-based care arrangements at OptumHealth, almost 1 million new consumers across UnitedHealthcare’s Medicare Advantage offerings, and a total more than 1.5 billion scripts to the people who rely on OptumRx.